期刊文献+

血浆β_2-微球蛋白、H-CRP、HCY与外周动脉粥样硬化病的风险分级关系 被引量:4

Risk classification of plasma β2-microglobulin, high-CRP, HCY and peripheral atherosclerosis disease
在线阅读 下载PDF
导出
摘要 目的探讨外周动脉粥样硬化病(PAD)风险分级与血浆β2-微球蛋白(β2-microglobulin,β2-MG)、高敏C反应蛋白(high-sensitivity C-reactive protein H-CRP)和同型半胱氨酸(homocysteine,HCY)关系。方法对沧州市人民医院普外(血管外科)2010年1月至2013年5月诊治的PAD患者96例进行分级。按ABI值分为:低风险组(0.7≤ABI≤0.9,n=25),中风险组(0.4≤ABI<0.7,n=52)和高风险组(ABI<0.4,n=19)。均以同期40例健康者作为对照,比较各组的β2-MG、H-CRP、HCY的浓度,进行相关性分析。结果血清β2-MG、H-CRP、HCY的浓度随着ABI分期的进展而升高,ABI的数值与β2-MG、H-CRP、HCY的浓度呈负相关(P<0.05)。结论 PAD随着病情的严重程度,血浆中的β2-MG、H-CRP、HCY浓度逐渐升高;β2-MG、H-CRP和HCY联合测定与ABI分级结合有助于更好地判断PAD患者的诊断和预后。 Objective To investigate the peripheral atherosclerotic disease (PAD) risk classiifcation and plasmaβ2-microglobulin (β2-microglobulin, β2-MG) high-sensitivity C-reactive protein (H-CRP) of homocysteine (HCY) relationship. Methods From January, 2010 to May, 2013 96 PAD patients were graded and treated in our hospital. According to the ABI value they were divided into: low risk group (0.7≤ABI≤0.9, n=25), medium risk group (0.4≤ABI 〈 0.7, n=52), and the high risk group (ABI 〈 0.4, n=19). 40 healthy persons served as the controls the concentration of β2-microglobulin, high CRP, HCY and their correlation were analyzed. Results The concentration of serumβ2-MG, H-CRP, HCY increased with the ABI stage and the progress, the concentrations were negatively correlated with ABI value with a beta 2-microglobulin H-CRP HCY. Conclusion PAD with the severity of the condition, in the plasmaβ2-MG H-CRP HCY concentration increased gradually,the joint determination ofβ2-MG H-CRP HCY and ABI combined with a hierarchical diagnosis and prognosis of patients with PAD is helpful to make sound diagnosis.
机构地区 沧州市人民医院
出处 《医学研究与教育》 CAS 2015年第2期40-43,共4页 Medical Research and Education
关键词 外周动脉粥样硬化病 β2-微球蛋白 ABI H-CRP HCY peripheral atherosclerotic disease β2-microglobulin ABI H-CRP HCY
  • 相关文献

参考文献5

二级参考文献33

共引文献53

同被引文献34

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部